Visit Us at Booth #3005!

EBCI ATTENDING  #ASCO23

June 2nd - 6th, 2023 Booth #3005

Why are we attending ASCO?

EBCI focuses on brain disease education, outreach, and awareness to this patient community and their families...worldwide; as well as to the general public; about treatments, studies, clinical trials, devices, diagnostics, genomic testing etc. One of the primary platforms used to deliver this disease education is via our digital footprint; thanks to our accomplished social/digital team. In 2020 our outbound education and communications resulted in a total of over 18 million opportunities for brain tumor disease awareness, education and outreach. With the development of our new APP in 2022, our Outreach via social media, e-newsletters, website, blogs, online support groups, online forums and in conjunction with our existing distribution partnerships via CURE Magazine, MJH Life Sciences Publishing and Cox Media; we expect this number to exponentially increase. 

Would you like to partner with The EndBrainCancer Initiative (EBCI)? Our team will be at ASCO through the 6th of June. If you'd like to meet to discuss potential partnership opportunities for your company, please contact our founder, Dellann Elliott Mydland, directly at 425-785-8489 or dellann@endbraincancer.org.